IGF1 and neoplasm: This specialized niche enhances tumor cell survival by providing growth factors and anti-apoptotic signals, facilitates immune evasion through the suppression of cytotoxic immune responses, and promotes active remodeling of the bone matrix, releasing cytokines such as TGF-β and IGF-1 that further drive tumor proliferation.